Advances in Predictive Biomarkers for Immune Checkpoint Inhibitors in Lung Cancer: Why, Who, and How

Review this program to get up to date on the latest data informing optimal integration of immunotherapy biomarkers into the management of patients with lung cancer including an on-demand Webcast capturing discussion by medical oncology and pathology experts from a symposium at the 2019 Clinical Pathology meeting and downloadable slidesets.

Share

Program Content

Activities

ICIs Across Lung Cancer
The Why and Who: Overview of Immune Checkpoint Blockade in Lung Cancer
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: November 05, 2019

Expires: November 03, 2020

PD-L1 and Molecular Testing in Lung Cancer
The How: Current Predictors of Response to Immune Checkpoint Inhibitors
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: November 05, 2019

Expires: November 03, 2020

Emerging ICI Biomarkers
The Future: Opportunities for Predictive Biomarkers for Cancer Immunotherapy
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: November 05, 2019

Expires: November 03, 2020

Activities

IO Biomarkers in Lung Cancer
Advances in Predictive Biomarkers for Immune Checkpoint Inhibitors in Lung Cancer: Why, Who, and How
Multimedia
Congratulations: You achieved a completion on 04/09/2022

Released: October 08, 2019

Expires: October 07, 2020

Faculty

cover img faculity

Hossein Borghaei, MS, DO

Associate Professor
Chief,
Thoracic Medical Oncology
Department of Hematology and Oncology
Fox Chase Cancer Center
Philadelphia, Pennsylvania

cover img faculity

Heather J. Jackson, PhD, FNP-BC, NEA-BC, FAANP

Associate Professor
Division of Hematology/Oncology
Department of Medicine
Vanderbilt University School of Nursing
Administrative Director of Advanced Practice
Division of Hematology/Oncology
Department of Medicine
Vanderbilt University Medical Center
Nashville, Tennessee

cover img faculity

Joshua Bauml, MD

Instructor, Division of Hematology/Oncology
Perelman School of Medicine at the University of Pennsylvania
Staff Physician
Philadelphia VA Medical Center
Philadelphia, Pennsylvania

cover img faculity

Sanjay Mukhopadhyay, MD

Director, Pulmonary Pathology
Department of Pathology
Cleveland Clinic
Cleveland, Ohio

cover img faculity

Sandip P. Patel, MD

Professor, Medical Oncology, UC San Diego
Leader, Experimental Therapeutics
Deputy Director, Sanford Stem Cell Clinical Center
Co-Leader, Solid Tumor Therapeutics Program
Medical Director, Clinical Research Informatics
La Jolla, California

cover img faculity

Sandip P. Patel, MD

Associate Professor
Department of Medicine
Division of Hematology/Oncology
University of California San Diego
San Diego, California

Provided by

ProCE Banner

Supporters

Supported by educational grants from

AstraZeneca

Bristol Myers Squibb

Genentech TEXT Only

Merck Sharp & Dohme Corp.